Mail & Guardian
Mail & Guardian
avaclatest news & developments
After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities are settling in. We spoke to Mitchell Warren from the New York HIV advocacy organisation, Avac, to find out what that means for South Africa. Photo: Paul Botes
AVAC

What will HIV funding look like in 2026?

After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities are settling in

  • Mia Malan
  • Tanya Pampalone
9 min read
Research indicates the anti-HIV jab, lenacapavir, protects women completely and works almost as well for men, transgender and nonbinary people. Photo: Marko Milivojevic/Pixnio
ANTIRETROVIRAL DRUGS

SA gets R520 million to buy the twice-a-year anti-HIV jab – but there’s a snag

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it has already been awarded and was cut by 16% in June

  • Mia Malan
8 min read
Prevention and treatment: Selena Bishop attends a consultation at Sorgin Health Centre in Nsanje, Malawi. Bishop is HIV positive is collecting her ARV refill. New research has found a bimonthly injection to be highly effective in preventing new HIV infections. Photo: Luca Sola
ANTIRETROVIRALS

Six injections a year could stop new HIV infections

New research from seven countries in Africa signals the future of HIV prevention — but what can it learn from its past?

  • Laura López González
7 min read